Clofarabine is a purine nucleoside antimetabolite in Europe and Australia/New Zealand the product is marketed under the name Evoltra.

Market Analysis and Insights: Global and China Evoltra Market
This report focuses on global and China Evoltra market.
In 2020, the global Evoltra market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Evoltra market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Evoltra Scope and Market Size
Evoltra market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Evoltra market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Evoltra market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Prefilled
Non-prefilled

Segment by Application
Hospital
Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Genzyme Corporation